Morgan Stanley Capital Services LLC Rule 38.5 - ALLERGAN PLC (4899M)
11 Mayo 2020 - 4:53AM
UK Regulatory
TIDM0Y7T
RNS Number : 4899M
Morgan Stanley Capital Services LLC
11 May 2020
FORM 38.5
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT,
1997, TAKEOVER RULES, 2007 (AS AMENDED)
DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS
1. KEY INFORMATION
Name of exempt market-maker Morgan Stanley Capital Services
LLC
Company dealt in ALLERGAN PLC
---------------------------------
Class of relevant security to US$0.0001 ORDINARY SHARES
which the dealings being disclosed
relate (Note 1)
---------------------------------
Date of dealing 08 MAY 2020
---------------------------------
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of relevant Highest price paid Lowest price paid (Note
secuities accquired (Note 3) 3)
1,187,694 193.0200 USD 191.9100 USD
------------------- ------------------------
Total number of relevant Highest price paid Lowest price paid (Note
secuities disposed (Note 3) 3)
13,206 193.0200 USD 193.0200 USD
------------------- ------------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant Price per unit
e.g. CFD (Note 4) securities
(Note 5)
CFD LONG 1 193.0200 USD
---------------------- ------------------- ---------------
CFD SHORT 6 191.9100 USD
---------------------- ------------------- ---------------
CFD SHORT 100 192.1400 USD
---------------------- ------------------- ---------------
CFD SHORT 7,000 192.9277 USD
---------------------- ------------------- ---------------
CFD SHORT 414,700 193.0200 USD
---------------------- ------------------- ---------------
CFD SHORT 710,000 193.0200 USD
---------------------- ------------------- ---------------
CFD SHORT 5,000 193.0200 USD
---------------------- ------------------- ---------------
CFD SHORT 11,000 193.0200 USD
---------------------- ------------------- ---------------
CFD SHORT 12,000 193.0200 USD
---------------------- ------------------- ---------------
CFD SHORT 22,000 193.0200 USD
---------------------- ------------------- ---------------
(c) Options transactions in respect of existing relevant securities
i) Writing, selling, purchasing or varying
Product Writing, Number Exercise Type, e.g Expiry Option
name, eg selling, of securities Price American, Date money paid/received
call option purchasing, to which European per unit
varying the option etc (Note 3)
etc relates
(Note 5)
N/A N/A N/A N/A N/A N/A N/A
------------- --------------- --------- ----------- ------- ---------------------
(ii) Exercising
Product name, eg call Number of securities Exercise price per
option unit (Note 3)
N/A N/A N/A
--------------------- -------------------
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full Details of any agreement, arrangement or understanding between
the person disclosing and any other person relating to the voting
rights of any relevant securities under any option referred to
on this form or relating to the voting rights or future acquisition
or disposal of any relevant securities to which any derivative
referred to on this form is referenced. If none, this should
be stated.
Date of disclosure 11 MAY 2020
Contact Name Craig Horsley
-----------------
Telephone Number +44(141) 245 7736
-----------------
Name of offeree/offeror with ABBVIE INC.
which connected
-----------------
Nature of connection (Note 6) Advisory
-----------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ISEKKDBPCBKKBPD
(END) Dow Jones Newswires
May 11, 2020 05:53 ET (09:53 GMT)
Allergan (LSE:0Y7T)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Allergan (LSE:0Y7T)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
